--- title: "ICF International (ICFI) To Report Earnings Tomorrow: Here Is What To Expect" type: "News" locale: "en" url: "https://longbridge.com/en/news/285302355.md" description: "ICF International (ICFI) will report earnings tomorrow after market close. Last quarter, the company beat revenue expectations with $443.7 million, but missed EPS estimates. Analysts expect an 8% revenue decline this quarter. Despite past misses, analysts have maintained their estimates, indicating stability. Peers like Jacobs Solutions and UL Solutions have shown positive growth, contributing to a favorable sentiment in the professional services sector. ICF's stock has risen 9.2% recently, with an average analyst price target of $105.25, compared to its current price of $73.85." datetime: "2026-05-06T03:01:53.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285302355.md) - [en](https://longbridge.com/en/news/285302355.md) - [zh-HK](https://longbridge.com/zh-HK/news/285302355.md) --- # ICF International (ICFI) To Report Earnings Tomorrow: Here Is What To Expect Professional consulting firm ICF International will be announcing earnings results this Thursday after market close. Here’s what to expect. ICF International beat analysts’ revenue expectations last quarter, reporting revenues of $443.7 million, down 10.6% year on year. It was a mixed quarter for the company, with a narrow beat of analysts’ revenue estimates but a miss of analysts’ EPS estimates. Is ICF International a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members. This quarter, the market is expecting ICF International’s revenue to decline 8% year on year, a further deceleration from the 1.4% decrease it recorded in the same quarter last year. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. ICF International has missed Wall Street’s revenue estimates multiple times over the last two years. Looking at ICF International’s peers in the professional services segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Jacobs Solutions delivered year-on-year revenue growth of 8.8%, beating analysts’ expectations by 2%, and UL Solutions reported revenues up 7.5%, topping estimates by 1.2%. Read our full analysis of Jacobs Solutions’s results here and UL Solutions’s results here. There has been positive sentiment among investors in the professional services segment, with share prices up 11% on average over the last month. ICF International is up 9.2% during the same time and is heading into earnings with an average analyst price target of $105.25 (compared to the current share price of $73.85). **ALSO WORTH WATCHING: Nvidia’s Quiet Partner.** Nvidia’s chips cost a hundred grand. The connectors that make them work cost even more. One company makes them all. Every AI server needs specialized infrastructure the chip companies don’t make. High-speed cables. Power connectors. Thermal sensors. This 90-year-old company built a monopoly on it. The AI boom just started. This stock is still flying under the radar. **Claim The Stock Ticker Here for FREE**. ### Related Stocks - [ICFI.US](https://longbridge.com/en/quote/ICFI.US.md) - [J.US](https://longbridge.com/en/quote/J.US.md) - [ULS.US](https://longbridge.com/en/quote/ULS.US.md) - [NVDA.US](https://longbridge.com/en/quote/NVDA.US.md) - [NVD.DE](https://longbridge.com/en/quote/NVD.DE.md) ## Related News & Research - [Insider Confidence On Display: MICHAEL HANDEL VAN Acquires $491K In ICF International Stock](https://longbridge.com/en/news/286939487.md) - [ICF International Reaffirms Steady Risk Profile with No New Material Threats Reported](https://longbridge.com/en/news/285799307.md) - [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md) - [Tuesday 5/19 Insider Buying Report: ZBIO, ICFI](https://longbridge.com/en/news/286954937.md) - [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)